ASX M&A Cycle: Why 2026 Could Be A Turning Point

Australia’s Next M&A Cycle Is Quietly Taking Shape

Australia’s softer equity market, higher funding costs, and uneven earnings backdrop are starting to create the kind of conditions that typically precede a more opportunistic M&A cycle, particularly across mid caps and structurally challenged sectors where sentiment has already turned fragile.

For long term investors, periods like this are uncomfortable in the short run, but they often lay the groundwork for far more attractive entry points across potential targets, active bidders, and even the advisory ecosystem that benefits from rising deal activity.

From Resilience to Something More Fragile

After several years defined by valuation compression, policy uncertainty, and a steady flow of earnings downgrades, Australian equities are entering 2026 at a genuine inflection point where fundamentals are improving, but the market still feels like it has very little margin for error if anything slips.

Recent outlooks suggest returns are likely to slow from here, with earnings needing to carry more weight as the easy gains from multiple expansion have largely played out, and that shift alone tends to make markets more sensitive to disappointment.

At the same time, volatility has not disappeared. Most base cases still assume at least one meaningful drawdown in 2026, somewhere in that 10 to 15 percent range, which keeps sentiment fragile and creates windows where pricing can disconnect from underlying value.

That combination, softer valuations in pockets of the market, mixed confidence, and periodic risk off moves, is usually where more patient buyers begin to step in and take advantage of short term dislocation.

M&A Activity Has Slowed, But It Hasn’t Disappeared

Deal activity across Australia has clearly come off the highs seen in 2021 and 2022, but what is interesting is not the slowdown itself, it is how the nature of deals is evolving into something more strategic and selective rather than purely driven by cheap capital.

Recent estimates put Australian deal value at roughly US$79.5 billion in 2025, down modestly year on year, with total deal volumes still holding up reasonably well, which suggests underlying appetite remains intact even if pricing discipline has returned.

There has also been a noticeable shift towards smaller transactions, particularly sub $100 million deals, highlighting how the market has already adjusted to a more cautious environment where capital is no longer as freely available as it once was.

Public markets, meanwhile, are playing a bigger role again. Take privates have become more common, especially with private equity finding fewer opportunities in traditional private channels and instead looking to listed markets where valuations have reset.

The Key Currents Driving This Cycle

A few themes are starting to stand out more clearly as we move into 2026. Inbound capital remains strong, with foreign buyers accounting for a larger share of deal value, particularly from US based strategics and private equity funds that still have capital to deploy.

Sector focus is also narrowing. Resources, financials, and energy transition assets are attracting the most attention, while technology, real estate, and healthcare continue to sit firmly on most buyers’ watchlists.

Private equity has become more active in listed markets, driving a steady pipeline of take privates as opportunities elsewhere become harder to source at attractive valuations.

At the same time, regulation is becoming more of a factor. Higher scrutiny, increased filing costs, and tighter merger controls are adding friction, particularly for consolidation strategies that rely on scale.

Why Downturns Tend to Accelerate Deal Activity

The first and most obvious catalyst is valuation reset. After a long period where prices ran ahead of earnings, parts of the Australian market still look expensive on a historical basis, and any broad correction tends to bring quality assets back into a range where buyers are more willing to engage.

The second driver is balance sheet pressure. Companies that managed through the low rate environment with higher leverage can quickly find themselves constrained when refinancing costs rise and growth slows, which often forces boards to consider options they might have previously avoided.

In those situations, trade sales, mergers, or recapitalisations become more realistic outcomes, particularly if equity markets are not supportive of raising fresh capital on reasonable terms.

There is also a strategic element that tends to accelerate in weaker markets. Companies simplify, divest non core assets, and refocus on areas where they have genuine competitive strength, which naturally creates more opportunities for transactions.

What the Historical Playbook Tells Us

Each cycle is different, but the patterns are often familiar. You tend to see take privates of de rated mid caps that still generate solid cash flow or hold valuable intellectual property, particularly where public markets are not recognising that value.

There is usually a wave of consolidation in fragmented industries, where margin pressure exposes smaller operators that simply do not have the scale to compete effectively. Foreign bidders also become more active, especially when local assets are trading at a discount to global peers, creating an arbitrage opportunity that is hard to ignore.

This time around, early signs of that pattern are already emerging across resources, healthcare, and parts of the technology sector.

Where the Next Wave of Deals May Emerge

Several parts of the market look particularly exposed to a pickup in opportunistic M&A activity.

Mid Cap Resources

Earnings remain highly leveraged to commodity prices, and many smaller players are still dependent on external capital, which makes them vulnerable if market conditions tighten further.

Energy Transition Assets

The long term growth story is clear, but these assets are capital intensive and often sub scale, creating a natural pathway for consolidation or strategic investment.

Listed Property and REITs

Valuations remain sensitive to interest rates, while underlying asset backing can make them attractive for privatisation strategies if pricing dislocates.

Technology and Software

Multiples have already compressed significantly from earlier highs, but many businesses still have strong customer bases and recurring revenue, which is exactly what private equity looks for.

Healthcare and Services

Demographic demand remains supportive, and fragmentation across the sector continues to create opportunities for platform building and roll ups.

How Investors Can Position From Here

For investors, a potential M&A cycle is not about hoping for weaker markets, but it does shift how risk and opportunity should be framed over the next 12 to 24 months.

The first step is identifying genuinely “biddable” companies. These are businesses with strong underlying assets, whether that is brand, infrastructure, licences, or intellectual property, combined with reasonable balance sheets, but where sentiment has driven valuations below long term averages.

It is also important to distinguish between forced sellers and strategic sellers. Companies under pressure are more likely to accept lower premiums, while those selling from a position of strength will typically command full value.

Tracking the buyer side matters just as much. Global private equity, particularly from the US, still has significant capital available, and listed acquirers with strong balance sheets are often in the best position to take advantage of weaker conditions.

Finally, regulatory risk cannot be ignored. Increased scrutiny can delay or even block transactions, particularly in concentrated industries, which means any investment thesis that relies heavily on a deal outcome needs to factor in that uncertainty.